Tscan Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Tscan Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Tscan Therapeutics Inc
Rating: 1.73358325
Author: Trendlyne DVM scores

about

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid ...

1.15 -0.03 (-2.54%)

55.25% Fall from 52W High

280.7K

XNAS Volume

XNAS 11 Mar, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

24.3 / 100

Technically Neutral

45.0 / 100

1Yr Price target upside is 422%

4 analysts

Tscan Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Tscan Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid ...

55.25% Fall from 52W High

SWOT Analysis

Tscan Therapeutics Inc Live Price Chart